{"id":2777,"date":"2026-06-29T18:42:42","date_gmt":"2026-06-29T21:42:42","guid":{"rendered":"https:\/\/inovamed.pro\/?p=2777"},"modified":"2026-06-29T18:45:17","modified_gmt":"2026-06-29T21:45:17","slug":"2777","status":"publish","type":"post","link":"https:\/\/inovamed.pro\/?p=2777","title":{"rendered":"Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea"},"content":{"rendered":"<div id=\"cfm-root\" class=\"ino-fullbleed\">\n    <style>\n        @import url('https:\/\/fonts.googleapis.com\/css2?family=Outfit:wght@300;400;500;600;700;800&display=swap');\n        @scope (#cfm-root) {\n            :scope {\n                --primary: #0066CC;\n                --secondary: #00A859;\n                --accent: #FF6B35;\n                --dark: #1E293B;\n                --light: #F8FAFC;\n                --gradient: linear-gradient(135deg, var(--primary), var(--secondary));\n                --gradient-accent: linear-gradient(135deg, var(--accent), #FF8C61);\n            }\n            * { margin: 0; padding: 0; box-sizing: border-box; }\n            :scope { font-family: 'Outfit', sans-serif; color: var(--dark); line-height: 1.8; background: var(--light); overflow-x: hidden; text-rendering: optimizeLegibility; }\n            .nav-buttons { position: fixed; bottom: 30px; right: 30px; z-index: 999; display: flex; flex-direction: column; gap: 12px; }\n            .nav-btn { width: 56px; height: 56px; border-radius: 50%; background: var(--gradient); color: white; border: none; cursor: pointer; font-size: 1.3rem; box-shadow: 0 6px 24px rgba(0,102,204,0.3); transition: all 0.3s; display: flex; align-items: center; justify-content: center; text-decoration: none; }\n            .nav-btn:hover { transform: translateY(-4px); box-shadow: 0 8px 32px rgba(0,102,204,0.4); }\n            .nav-btn.secondary { background: linear-gradient(135deg, #64748B, #475569); }\n            .language-toggle { position: fixed; top: 20px; right: 20px; z-index: 1000; background: white; padding: 12px 24px; border-radius: 30px; box-shadow: 0 4px 20px rgba(0,0,0,0.1); display: flex; gap: 15px; align-items: center; }\n            .lang-btn { background: none; border: 2px solid var(--primary); color: var(--primary); padding: 8px 20px; border-radius: 20px; cursor: pointer; font-weight: 600; transition: all 0.3s; font-family: 'Outfit', sans-serif; }\n            .lang-btn.active { background: var(--gradient); color: white; border-color: transparent; }\n            .lang-btn:hover { transform: translateY(-2px); box-shadow: 0 4px 12px rgba(0,102,204,0.3); }\n            .hero { background: var(--gradient); color: white; padding: 120px 20px 80px; text-align: center; position: relative; overflow: hidden; }\n            .hero::before { content: ''; position: absolute; top: -50%; right: -10%; width: 600px; height: 600px; background: rgba(255,255,255,0.08); border-radius: 50%; animation: cfm-float 20s infinite ease-in-out; }\n            .hero h1 { font-size: clamp(2rem, 5vw, 3rem); font-weight: 800; margin-bottom: 25px; line-height: 1.2; position: relative; z-index: 1; }\n            .hero .subtitle { font-size: clamp(1.05rem, 3vw, 1.3rem); margin-bottom: 20px; opacity: 0.95; font-weight: 400; line-height: 1.6; max-width: 900px; margin-left: auto; margin-right: auto; }\n            .hero .meta-info { font-size: clamp(0.9rem, 2.5vw, 1rem); opacity: 0.9; margin-top: 25px; font-weight: 500; }\n            .hero .date { font-size: clamp(0.85rem, 2vw, 0.95rem); opacity: 0.85; margin-top: 12px; font-style: italic; }\n            .deadline-badge { display: inline-block; background: rgba(255,255,255,0.18); border: 2px solid rgba(255,255,255,0.55); color: white; padding: 12px 30px; border-radius: 30px; font-size: 1.05rem; font-weight: 700; margin-top: 25px; position: relative; z-index: 1; letter-spacing: 0.02em; }\n            .container { width: 100%; max-width: 1200px; margin: 0 auto; padding: clamp(40px, 8vw, 80px) clamp(15px, 4vw, 20px); }\n            .section { margin-bottom: 80px; }\n            .section-title { font-size: clamp(1.8rem, 4.5vw, 2.3rem); font-weight: 700; margin-bottom: 30px; color: var(--dark); position: relative; padding-bottom: 15px; }\n            .section-title::after { content: ''; position: absolute; bottom: 0; left: 0; width: 80px; height: 4px; background: var(--gradient); border-radius: 2px; }\n            .toc { background: linear-gradient(135deg, #ffffff, #f8fafc); padding: clamp(30px, 5vw, 50px) clamp(25px, 4vw, 45px); border-radius: 24px; margin-bottom: 60px; box-shadow: 0 15px 60px rgba(0,0,0,0.12); border: 1px solid rgba(0,102,204,0.1); position: relative; overflow: hidden; }\n            .toc::before { content: ''; position: absolute; top: 0; left: 0; width: 6px; height: 100%; background: var(--gradient); }\n            .toc h2 { font-size: clamp(1.6rem, 3.5vw, 2rem); color: var(--dark); margin-bottom: 15px; font-weight: 700; display: flex; align-items: center; gap: 15px; }\n            .toc h2::before { content: '\ud83e\udded'; font-size: 1.8rem; }\n            .toc-subtitle { font-size: 1.05rem; color: #64748B; margin-bottom: 35px; font-weight: 400; }\n            .toc ul { list-style: none; padding-left: 0; display: grid; grid-template-columns: 1fr; gap: 12px; }\n            .toc ul li { margin-bottom: 0; }\n            .toc ul li a { display: flex; align-items: center; gap: 15px; text-decoration: none; color: var(--dark); font-weight: 600; font-size: clamp(0.95rem, 2.5vw, 1.1rem); padding: 18px 22px; background: white; border-radius: 12px; transition: all 0.3s; border: 2px solid transparent; box-shadow: 0 2px 8px rgba(0,0,0,0.04); }\n            .toc ul li a::before { content: ''; width: 8px; height: 8px; background: var(--gradient); border-radius: 50%; flex-shrink: 0; }\n            .toc ul li a:hover { transform: translateX(8px); border-color: var(--primary); box-shadow: 0 8px 24px rgba(0,102,204,0.15); background: linear-gradient(135deg, #ffffff, #f0f9ff); }\n            .intro-box { background: white; padding: clamp(25px, 4vw, 40px); border-radius: 20px; box-shadow: 0 10px 40px rgba(0,0,0,0.08); margin-bottom: 60px; border-left: 6px solid var(--primary); }\n            .intro-box p { font-size: clamp(1rem, 2.8vw, 1.15rem); line-height: 1.9; margin-bottom: 20px; text-align: justify; }\n            .intro-box p:last-child { margin-bottom: 0; }\n            .intro-box strong { color: var(--primary); font-weight: 700; }\n            .detailed-section { background: white; padding: clamp(30px, 5vw, 50px); border-radius: 20px; box-shadow: 0 10px 40px rgba(0,0,0,0.08); margin: 40px 0; }\n            .detailed-section h3 { font-size: clamp(1.5rem, 3.8vw, 1.8rem); color: var(--primary); margin-bottom: 20px; font-weight: 700; }\n            .detailed-section h4 { font-size: clamp(1.2rem, 3vw, 1.4rem); color: var(--dark); margin: 28px 0 16px; font-weight: 600; }\n            .detailed-section p { font-size: clamp(1rem, 2.5vw, 1.1rem); line-height: 1.9; margin-bottom: 18px; text-align: justify; }\n            .detailed-section ul, .detailed-section ol { font-size: clamp(1rem, 2.5vw, 1.1rem); line-height: 1.9; margin: 16px 0 16px 30px; padding-left: 20px; }\n            .detailed-section li { margin-bottom: 8px; }\n            .highlight-box { background: linear-gradient(135deg, #E6F3FF, #D6EBFF); padding: clamp(25px, 4vw, 40px); border-radius: 15px; margin: 40px 0; border-left: 6px solid var(--primary); }\n            .highlight-box h4 { font-size: clamp(1.2rem, 3vw, 1.4rem); color: var(--primary); margin-bottom: 18px; font-weight: 700; }\n            .highlight-box p { font-size: clamp(1rem, 2.8vw, 1.1rem); line-height: 1.8; margin-bottom: 12px; text-align: justify; }\n            .highlight-box strong { color: var(--primary); font-weight: 700; }\n            .highlight-box ul { font-size: clamp(1rem, 2.5vw, 1.05rem); line-height: 1.9; margin: 14px 0 14px 28px; padding-left: 18px; }\n            .highlight-box li { margin-bottom: 8px; }\n            .warning-box { background: linear-gradient(135deg, #FFF9E6, #FFF3D6); padding: clamp(25px, 4vw, 40px); border-radius: 15px; margin: 40px 0; border-left: 6px solid var(--accent); }\n            .warning-box h4 { font-size: clamp(1.2rem, 3vw, 1.4rem); color: var(--accent); margin-bottom: 18px; font-weight: 700; }\n            .warning-box p { font-size: clamp(1rem, 2.8vw, 1.1rem); line-height: 1.9; margin-bottom: 14px; text-align: justify; }\n            .warning-box strong { color: #C05800; font-weight: 700; }\n            .warning-box ul { font-size: clamp(1rem, 2.5vw, 1.05rem); line-height: 1.9; margin: 14px 0 14px 28px; padding-left: 18px; }\n            .warning-box li { margin-bottom: 8px; }\n            .science-box { background: linear-gradient(135deg, #E6FFF6, #CCFFE6); border: 2px solid var(--secondary); border-radius: 15px; padding: clamp(25px, 4vw, 35px); margin: 30px 0; }\n            .science-box h4 { color: var(--secondary); font-weight: 700; font-size: 1.3em; margin-bottom: 15px; display: flex; align-items: center; }\n            .science-box h4::before { content: \"\ud83d\udca1\"; margin-right: 10px; }\n            .science-box p { font-size: 1.05rem; text-align: justify; margin-bottom: 14px; line-height: 1.85; }\n            .science-box p:last-child { margin-bottom: 0; }\n            .alert-box { background: linear-gradient(135deg, #FFF0F0, #FFE0E0); border: 2px solid #FC8181; border-radius: 15px; padding: clamp(25px, 4vw, 35px); margin: 30px 0; }\n            .alert-box h4 { color: #C53030; font-weight: 700; font-size: 1.3em; margin-bottom: 15px; }\n            .alert-box p { font-size: 1.05rem; text-align: justify; margin-bottom: 14px; line-height: 1.85; }\n            .alert-box strong { color: #C53030; }\n            .flow-box { background: radial-gradient(circle at top left, #1e293b, #020617); color: #e5e7eb; border-radius: 22px; padding: 28px 26px; margin: 40px 0; box-shadow: 0 18px 50px rgba(15,23,42,0.65); border: 1px solid rgba(148,163,184,0.4); position: relative; overflow: hidden; }\n            .flow-box::before { content: \"\"; position: absolute; top: -80px; right: -80px; width: 220px; height: 220px; background: radial-gradient(circle, rgba(56,189,248,0.35), transparent 70%); opacity: 0.5; }\n            .flow-box h4 { font-size: clamp(1.35rem, 3vw, 1.6rem); margin-bottom: 8px; font-weight: 700; display: flex; align-items: center; gap: 10px; color: #f9fafb; text-shadow: 0 2px 8px rgba(0,0,0,0.7); }\n            .flow-box h4::before { content: \"\ud83d\udcc5\"; font-size: 1.4rem; }\n            .flow-box p.flow-intro { font-size: 0.98rem; opacity: 0.9; max-width: 650px; margin-bottom: 0; }\n            .flow-steps { margin-top: 22px; display: flex; flex-wrap: wrap; gap: 14px; align-items: stretch; position: relative; z-index: 1; }\n            .flow-step { flex: 1 1 150px; background: rgba(15,23,42,0.92); border-radius: 16px; padding: 16px; border: 1px solid rgba(148,163,184,0.4); backdrop-filter: blur(4px); }\n            .flow-step.current { border-color: #60A5FA; border-width: 2px; background: rgba(20,50,100,0.95); }\n            .flow-step .step-label { font-size: 0.72rem; text-transform: uppercase; letter-spacing: 0.12em; color: #a5b4fc; margin-bottom: 5px; }\n            .flow-step.current .step-label { color: #93C5FD; }\n            .flow-step .step-title { font-size: 0.95rem; font-weight: 700; margin-bottom: 5px; color: #e5e7eb; }\n            .flow-step .step-desc { font-size: 0.86rem; opacity: 0.88; line-height: 1.5; }\n            .flow-arrow { font-size: 1.6rem; align-self: center; padding: 0 4px; opacity: 0.8; }\n            .table-wrapper { overflow-x: auto; -webkit-overflow-scrolling: touch; margin: 40px 0; border-radius: 15px; box-shadow: 0 8px 30px rgba(0,0,0,0.06); }\n            .data-table { width: 100%; min-width: 620px; border-collapse: collapse; background: white; overflow: hidden; }\n            .data-table th, .data-table td { padding: 18px 20px; text-align: left; border-bottom: 1px solid #E2E8F0; }\n            .data-table th { background: var(--gradient); color: white; font-weight: 700; font-size: 1rem; }\n            .data-table td { font-size: 1rem; line-height: 1.6; vertical-align: top; }\n            .data-table tr:last-child td { border-bottom: none; }\n            .data-table tr:hover td { background: #F8FAFC; }\n            .status-badge { display: inline-block; padding: 5px 14px; border-radius: 20px; font-size: 0.88em; font-weight: 700; white-space: nowrap; }\n            .s-baixo { background: #C6F6D5; color: #22543D; }\n            .s-medio { background: #BEE3F8; color: #2A4365; }\n            .s-alto { background: #FEEBC8; color: #7C2D12; }\n            .s-inaceitavel { background: #E9D8FD; color: #44337A; }\n            .checklist-section { padding: 10px 0; }\n            .check-item { display: flex; align-items: flex-start; gap: 14px; padding: 12px 0; border-bottom: 1px solid rgba(0,102,204,0.1); }\n            .check-item:last-child { border-bottom: none; }\n            .check-icon { font-size: 1.25rem; flex-shrink: 0; margin-top: 1px; }\n            .check-text { flex: 1; line-height: 1.65; font-size: 1rem; }\n            .check-text strong { color: var(--primary); font-weight: 700; }\n            .check-subhead { font-size: 1.05rem; font-weight: 700; color: var(--dark); margin: 20px 0 10px; padding-bottom: 6px; border-bottom: 2px solid rgba(0,102,204,0.2); }\n            .cta-section { background: var(--gradient); color: white; padding: clamp(60px, 10vw, 80px) clamp(30px, 6vw, 40px); border-radius: 25px; text-align: center; margin: 80px 0; position: relative; overflow: hidden; }\n            .cta-section::before { content: ''; position: absolute; top: -50%; left: -50%; width: 600px; height: 600px; background: rgba(255,255,255,0.07); border-radius: 50%; animation: cfm-float 15s infinite ease-in-out; }\n            .cta-section h2 { font-size: clamp(1.8rem, 4.5vw, 2.3rem); margin-bottom: 25px; position: relative; z-index: 1; }\n            .cta-section p { font-size: clamp(1.05rem, 3vw, 1.2rem); margin-bottom: 20px; opacity: 0.95; position: relative; z-index: 1; line-height: 1.8; max-width: 800px; margin-left: auto; margin-right: auto; }\n            .cta-button { display: inline-block; background: white; color: var(--primary); padding: 15px 40px; border-radius: 30px; text-decoration: none; font-weight: 700; font-size: 1.1em; transition: all 0.3s ease; box-shadow: 0 4px 15px rgba(0,0,0,0.2); margin-top: 20px; position: relative; z-index: 1; }\n            .cta-button:hover { transform: translateY(-2px); box-shadow: 0 6px 20px rgba(0,0,0,0.3); }\n            .footer { background: var(--dark); color: white; padding: 50px 20px; text-align: center; }\n            .footer p { font-size: 1rem; opacity: 0.8; margin-bottom: 10px; line-height: 1.7; }\n            .reference-box { background: #F8FAFC; padding: clamp(22px, 4vw, 30px); border-radius: 15px; margin: 40px 0; border-left: 4px solid var(--secondary); }\n            .reference-box h4 { font-size: 1.2rem; color: var(--secondary); margin-bottom: 15px; font-weight: 700; }\n            .reference-box ol { font-size: 0.93rem; line-height: 1.85; color: #64748B; margin-left: 10px; padding-left: 20px; }\n            .reference-box li { margin-bottom: 10px; }\n            .divider { height: 1px; background: linear-gradient(90deg, transparent, rgba(0,102,204,0.25), transparent); margin: 50px 0; }\n            .hidden { display: none; }\n            .article-tag { display: inline-block; background: rgba(255,255,255,0.18); color: white; padding: 4px 16px; border-radius: 20px; font-size: 0.85rem; font-weight: 600; margin-bottom: 18px; border: 1px solid rgba(255,255,255,0.4); position: relative; z-index: 1; }\n            @media (max-width: 768px) {\n                .language-toggle { top: 10px; right: 10px; padding: 8px 16px; gap: 8px; }\n                .lang-btn { padding: 6px 14px; font-size: 0.9rem; }\n                .nav-buttons { bottom: 20px; right: 20px; }\n                .nav-btn { width: 50px; height: 50px; font-size: 1.1rem; }\n                .flow-steps { flex-direction: column; }\n                .flow-arrow { transform: rotate(90deg); text-align: center; }\n            }\n            @media (max-width: 480px) {\n                .container { padding: 30px 15px; }\n                .intro-box, .detailed-section, .highlight-box, .warning-box, .science-box, .alert-box { padding: 22px; }\n            }\n        }\n        @keyframes cfm-float { 0%, 100% { transform: translateY(0) rotate(0deg); } 50% { transform: translateY(-30px) rotate(180deg); } }\n        @keyframes cfm-fadeIn { from { opacity: 0; transform: translateY(10px); } to { opacity: 1; transform: translateY(0); } }\n    <\/style>\n<div class=\"nav-buttons\">\n    <a href=\"#top-pt\" id=\"nav-btn-top\" class=\"nav-btn\" title=\"Topo\">\u2191<\/a>\n    <a href=\"#indice-pt\" id=\"nav-btn-toc\" class=\"nav-btn secondary\" title=\"\u00cdndice\">\ud83e\udded<\/a>\n<\/div>\n<div class=\"language-toggle\">\n    <button class=\"lang-btn active\" onclick=\"switchLanguage('pt')\" id=\"btn-pt\">\ud83c\udde7\ud83c\uddf7 PT<\/button>\n    <button class=\"lang-btn\" onclick=\"switchLanguage('en')\" id=\"btn-en\">\ud83c\uddfa\ud83c\uddf8 EN<\/button>\n<\/div>\n<!-- ===================== CONTE\u00daDO PT ===================== -->\n<div id=\"content-pt\">\n    <section class=\"hero\" id=\"top-pt\">\n        <span class=\"article-tag\">Regula\u00e7\u00e3o \u00b7 IA na Medicina \u00b7 Pr\u00e1tica Cl\u00ednica<\/span>\n        <h1>Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea<\/h1>\n        <p class=\"subtitle\">A norma que muitos leram como amea\u00e7a \u00e9, na pr\u00e1tica, o trilho oficial que protege o m\u00e9dico que j\u00e1 usa intelig\u00eancia artificial. Um olhar de quem usa \u2014 e constr\u00f3i \u2014 IA na beira do leito.<\/p>\n        <p class=\"meta-info\">Dr. Mbula Luzingu Barros | M\u00e9dico Pediatra Intensivista \u00b7 25 anos de UTI Pedi\u00e1trica | Consultor em IA na Sa\u00fade | Fundador da INOVAMED | Criador da Metodologia AIMED<\/p>\n        <p class=\"date\">\ud83d\udcc5 Publicado em 29 de junho de 2026<\/p>\n        <div class=\"deadline-badge\">\u23f1 Vig\u00eancia da CFM 2.454 em: <span class=\"countdown-days\">58<\/span> dias \u2014 26 de agosto de 2026<\/div>\n    <\/section>\n    <div class=\"container\">\n        <nav class=\"toc\" id=\"indice-pt\">\n            <h2>Navegue pelo Artigo<\/h2>\n            <p class=\"toc-subtitle\">Do receio \u00e0 conduta de segunda-feira \u2014 por que a regra est\u00e1 a seu favor<\/p>\n            <ul>\n                <li><a href=\"#ctx-pt\">1. O Mal-Entendido: Por Que Tantos Leram Errado<\/a><\/li>\n                <li><a href=\"#garante-pt\">2. O Que a 2.454 de Fato Garante<\/a><\/li>\n                <li><a href=\"#risco-pt\">3. A Classifica\u00e7\u00e3o de Risco, na Pr\u00e1tica<\/a><\/li>\n                <li><a href=\"#informal-pt\">4. Da IA Informal \u00e0 IA Respaldada<\/a><\/li>\n                <li><a href=\"#alta-pt\">5. Caso Real: o Rob\u00f4 ALTA na UTI Neonatal<\/a><\/li>\n                <li><a href=\"#fazer-pt\">6. Checklist de Conformidade at\u00e9 26\/ago<\/a><\/li>\n                <li><a href=\"#final-pt\">7. Considera\u00e7\u00f5es Finais<\/a><\/li>\n                <li><a href=\"#ref-pt\">8. Refer\u00eancias<\/a><\/li>\n            <\/ul>\n        <\/nav>\n        <section class=\"section\" id=\"ctx-pt\">\n            <h2 class=\"section-title\">O Mal-Entendido: Por Que Tantos Leram Errado<\/h2>\n            <div class=\"intro-box\">\n                <p>Em 27 de fevereiro de 2026, o Conselho Federal de Medicina publicou no DOU a Resolu\u00e7\u00e3o CFM n\u00ba 2.454\/2026, que normatiza o uso de intelig\u00eancia artificial na medicina em todo o territ\u00f3rio nacional. As regras passam a valer em <strong>26 de agosto de 2026<\/strong> \u2014 180 dias ap\u00f3s a publica\u00e7\u00e3o. A leitura predominante foi de alarme: &#8220;o CFM apertou o cerco \u00e0 IA&#8221;.<\/p>\n                <p>Proponho a leitura oposta, e a fa\u00e7o de dentro do hospital. A resolu\u00e7\u00e3o n\u00e3o pro\u00edbe \u2014 ela <strong>organiza<\/strong>. Pela primeira vez existe um trilho oficial dizendo como voc\u00ea <em>pode<\/em> usar IA, com respaldo \u00e9tico, t\u00e9cnico e jur\u00eddico. Quem usava IA na surdina, sem rastro, carregava o risco sozinho. A partir de agora, h\u00e1 regra clara \u2014 e regra clara protege quem segue.<\/p>\n            <\/div>\n        <\/section>\n        <div class=\"divider\"><\/div>\n        <section class=\"section\" id=\"garante-pt\">\n            <h2 class=\"section-title\">O Que a 2.454 de Fato Garante<\/h2>\n            <div class=\"detailed-section\">\n                <p>A norma assegura, em texto expresso, o direito do m\u00e9dico de usar IA como apoio \u00e0 decis\u00e3o cl\u00ednica, \u00e0 gest\u00e3o, \u00e0 pesquisa e \u00e0 educa\u00e7\u00e3o m\u00e9dica continuada. Tr\u00eas pilares merecem destaque:<\/p>\n                <h4>Autonomia preservada<\/h4>\n                <p>A \u00faltima palavra sobre diagn\u00f3stico, terap\u00eautica e progn\u00f3stico permanece sempre do m\u00e9dico. Mais: o m\u00e9dico pode recusar tecnologias n\u00e3o validadas cientificamente, sem certifica\u00e7\u00e3o regulat\u00f3ria ou que contrariem princ\u00edpios \u00e9ticos, t\u00e9cnicos ou legais.<\/p>\n                <h4>Crit\u00e9rio objetivo de escolha<\/h4>\n                <p>A resolu\u00e7\u00e3o cria uma classifica\u00e7\u00e3o de risco \u2014 baixo, m\u00e9dio, alto e inaceit\u00e1vel \u2014 considerando impacto sobre direitos fundamentais, complexidade do modelo, grau de autonomia e sensibilidade dos dados.<\/p>\n                <h4>Direitos do paciente<\/h4>\n                <p>Informa\u00e7\u00e3o clara sobre o estado de sa\u00fade, direito \u00e0 segunda opini\u00e3o, prote\u00e7\u00e3o de dados pessoais e veda\u00e7\u00e3o a interven\u00e7\u00f5es experimentais sem consentimento espec\u00edfico.<\/p>\n            <\/div>\n            <div class=\"highlight-box\">\n                <h4>O ponto que muda a sua segunda-feira<\/h4>\n                <p>A IA apoia; o <strong>m\u00e9dico decide<\/strong>. Isso n\u00e3o \u00e9 uma limita\u00e7\u00e3o nova \u2014 \u00e9 a formaliza\u00e7\u00e3o do que a boa pr\u00e1tica j\u00e1 exigia. O que mudou \u00e9 que agora essa pr\u00e1tica tem amparo: seguir a norma deixou de ser burocracia e virou blindagem.<\/p>\n            <\/div>\n        <\/section>\n        <div class=\"divider\"><\/div>\n        <section class=\"section\" id=\"risco-pt\">\n            <h2 class=\"section-title\">A Classifica\u00e7\u00e3o de Risco, na Pr\u00e1tica<\/h2>\n            <div class=\"detailed-section\">\n                <p>Entender em que faixa cada ferramenta cai \u00e9 o que separa o uso defens\u00e1vel do uso temer\u00e1rio. A leitura aplicada ao cotidiano cl\u00ednico:<\/p>\n            <\/div>\n            <div class=\"table-wrapper\">\n                <table class=\"data-table\">\n                    <thead>\n                        <tr>\n                            <th>Faixa de risco<\/th>\n                            <th>Exemplo de uso cl\u00ednico<\/th>\n                            <th>Exig\u00eancia pr\u00e1tica<\/th>\n                        <\/tr>\n                    <\/thead>\n                    <tbody>\n                        <tr>\n                            <td><span class=\"status-badge s-baixo\">Baixo<\/span><\/td>\n                            <td>Resumo de literatura, apoio \u00e0 educa\u00e7\u00e3o m\u00e9dica<\/td>\n                            <td>Boas pr\u00e1ticas e transpar\u00eancia<\/td>\n                        <\/tr>\n                        <tr>\n                            <td><span class=\"status-badge s-medio\">M\u00e9dio<\/span><\/td>\n                            <td>Estrutura\u00e7\u00e3o de nota cl\u00ednica, triagem administrativa<\/td>\n                            <td>Valida\u00e7\u00e3o + supervis\u00e3o humana documentada<\/td>\n                        <\/tr>\n                        <tr>\n                            <td><span class=\"status-badge s-alto\">Alto<\/span><\/td>\n                            <td>Apoio \u00e0 decis\u00e3o diagn\u00f3stica\/terap\u00eautica \u00e0 beira do leito<\/td>\n                            <td>Certifica\u00e7\u00e3o, rastreabilidade e decis\u00e3o humana registrada<\/td>\n                        <\/tr>\n                        <tr>\n                            <td><span class=\"status-badge s-inaceitavel\">Inaceit\u00e1vel<\/span><\/td>\n                            <td>Decis\u00e3o cl\u00ednica aut\u00f4noma sem m\u00e9dico respons\u00e1vel<\/td>\n                            <td>Vedado<\/td>\n                        <\/tr>\n                    <\/tbody>\n                <\/table>\n            <\/div>\n            <div class=\"warning-box\">\n                <h4>\u26a0 Aten\u00e7\u00e3o: a classifica\u00e7\u00e3o \u00e9 obriga\u00e7\u00e3o sua<\/h4>\n                <p>Ferramenta de apoio \u00e0 decis\u00e3o \u00e0 beira do leito tende a cair na faixa de <strong>alto risco<\/strong>. Isso n\u00e3o a pro\u00edbe \u2014 exige certifica\u00e7\u00e3o, registro de vers\u00e3o do modelo e prova de que a decis\u00e3o final foi humana. E a avalia\u00e7\u00e3o formal de risco \u00e9 dever da institui\u00e7\u00e3o que usa, n\u00e3o do fornecedor que vende.<\/p>\n            <\/div>\n        <\/section>\n        <div class=\"divider\"><\/div>\n        <section class=\"section\" id=\"informal-pt\">\n            <h2 class=\"section-title\">Da IA Informal \u00e0 IA Respaldada<\/h2>\n            <div class=\"detailed-section\">\n                <p>O maior efeito pr\u00e1tico da 2.454 \u00e9 encerrar a era da &#8220;IA de bolso&#8221; \u2014 a conta pessoal gen\u00e9rica aberta no celular durante a visita, sem rastro e sem governan\u00e7a. O caminho seguro passa a ser a IA institucional, audit\u00e1vel e validada. N\u00e3o \u00e9 perda de agilidade: \u00e9 ganho de prote\u00e7\u00e3o.<\/p>\n            <\/div>\n            <div class=\"flow-box\">\n                <h4>A janela de adapta\u00e7\u00e3o<\/h4>\n                <p class=\"flow-intro\">Onde estamos hoje na linha do tempo da norma \u2014 e por que agir agora custa menos.<\/p>\n                <div class=\"flow-steps\">\n                    <div class=\"flow-step\">\n                        <div class=\"step-label\">At\u00e9 27\/02\/2026<\/div>\n                        <div class=\"step-title\">Era da IA informal<\/div>\n                        <div class=\"step-desc\">Uso pessoal, sem registro, risco integralmente sobre o m\u00e9dico.<\/div>\n                    <\/div>\n                    <div class=\"flow-arrow\">\u279c<\/div>\n                    <div class=\"flow-step current\">\n                        <div class=\"step-label\">29\/06\/2026 \u00b7 Voc\u00ea est\u00e1 aqui<\/div>\n                        <div class=\"step-title\">Janela de migra\u00e7\u00e3o aberta<\/div>\n                        <div class=\"step-desc\">58 dias para migrar \u00e0 ferramenta certificada, com log de uso e decis\u00e3o humana documentada.<\/div>\n                    <\/div>\n                    <div class=\"flow-arrow\">\u279c<\/div>\n                    <div class=\"flow-step\">\n                        <div class=\"step-label\">26\/08\/2026<\/div>\n                        <div class=\"step-title\">Vig\u00eancia plena<\/div>\n                        <div class=\"step-desc\">Deveres tornam-se exig\u00edveis. IA institucional como padr\u00e3o \u2014 mais seguran\u00e7a jur\u00eddica do que antes da norma.<\/div>\n                    <\/div>\n                    <div class=\"flow-arrow\">\u279c<\/div>\n                    <div class=\"flow-step\">\n                        <div class=\"step-label\">Ap\u00f3s<\/div>\n                        <div class=\"step-title\">Fiscaliza\u00e7\u00e3o dos CRMs<\/div>\n                        <div class=\"step-desc\">Conselhos Regionais iniciam supervis\u00e3o ativa. Quem se preparou usa IA com tranquilidade.<\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/section>\n        <div class=\"divider\"><\/div>\n        <section class=\"section\" id=\"alta-pt\">\n            <h2 class=\"section-title\">Caso Real: o Rob\u00f4 ALTA na UTI Neonatal<\/h2>\n            <div class=\"detailed-section\">\n                <p>Isso n\u00e3o \u00e9 teoria distante para n\u00f3s. O <strong>ALTA<\/strong> \u2014 rob\u00f4 de apoio \u00e0 decis\u00e3o cl\u00ednica que a INOVAMED apresentou no Harvard HSIL Hackathon, hub Bras\u00edlia, em abril de 2026 \u2014 entrou em fase de implementa\u00e7\u00e3o definitiva na nossa UTI neonatal.<\/p>\n                <p>O desenho operacional \u00e9 exatamente o que a 2.454 preconiza: a IA levanta o sinal e organiza a informa\u00e7\u00e3o; o <strong>neonatologista<\/strong> avalia, decide e assina cada conduta. A ferramenta n\u00e3o substitui o ju\u00edzo cl\u00ednico \u2014 amplia a capacidade de detec\u00e7\u00e3o precoce e libera tempo cognitivo da equipe. Estamos otimistas com o ganho no apoio \u00e0 decis\u00e3o.<\/p>\n            <\/div>\n            <div class=\"science-box\">\n                <h4>Connecting the Dots<\/h4>\n                <p>O ALTA \u00e9, ao mesmo tempo, ferramenta cl\u00ednica e prova de conceito regulat\u00f3ria. Construir a camada de auditoria \u2014 classifica\u00e7\u00e3o de risco mapeada, rastreabilidade de cada intera\u00e7\u00e3o e decis\u00e3o final humana sempre registrada \u2014 <em>antes<\/em> de a norma exigir n\u00e3o \u00e9 zelo excessivo.<\/p>\n                <p>\u00c9 o que transforma uma boa ideia de hackathon em tecnologia que sobrevive \u00e0 inspe\u00e7\u00e3o do Conselho. Quem desenha conformidade desde o prot\u00f3tipo n\u00e3o corre atr\u00e1s da regra \u2014 chega antes dela.<\/p>\n            <\/div>\n        <\/section>\n        <div class=\"divider\"><\/div>\n        <section class=\"section\" id=\"fazer-pt\">\n            <h2 class=\"section-title\">Checklist de Conformidade at\u00e9 26\/ago<\/h2>\n            <div class=\"highlight-box\">\n                <h4>O que garantir antes da vig\u00eancia<\/h4>\n                <div class=\"checklist-section\">\n                    <div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Valida\u00e7\u00e3o e certifica\u00e7\u00e3o.<\/strong> Garanta valida\u00e7\u00e3o cient\u00edfica e, quando aplic\u00e1vel, certifica\u00e7\u00e3o regulat\u00f3ria da ferramenta.<\/div><\/div>\n                    <div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Classifique o risco de cada uso.<\/strong> Mapeie baixo \/ m\u00e9dio \/ alto com base nos crit\u00e9rios do Art. 12 \u2014 \u00e9 dever da institui\u00e7\u00e3o.<\/div><\/div>\n                    <div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Registro audit\u00e1vel.<\/strong> Log de cada intera\u00e7\u00e3o m\u00e9dico\u2013IA: prompt, resposta, modelo, vers\u00e3o e data.<\/div><\/div>\n                    <div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Decis\u00e3o humana documentada.<\/strong> Campo obrigat\u00f3rio \u2014 nunca autopreenchido \u2014 registrando que o m\u00e9dico avaliou e assinou.<\/div><\/div>\n                    <div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>LGPD.<\/strong> Base legal e prote\u00e7\u00e3o de dados para qualquer dado de paciente processado; prefira pseudonimiza\u00e7\u00e3o.<\/div><\/div>\n                    <div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Direitos do paciente.<\/strong> Informa\u00e7\u00e3o clara sobre o uso de IA e respeito ao direito de segunda opini\u00e3o.<\/div><\/div>\n                <\/div>\n            <\/div>\n            <div class=\"alert-box\">\n                <h4>\u26a0 N\u00e3o deixe para depois<\/h4>\n                <p>S\u00e3o poucas semanas at\u00e9 26 de agosto. Mapear ferramentas e montar o log de auditoria agora \u00e9 mais barato do que adaptar sob press\u00e3o \u2014 e infinitamente mais barato do que responder a uma sindic\u00e2ncia sem rastro.<\/p>\n            <\/div>\n        <\/section>\n        <div class=\"cta-section\">\n            <h2>Use IA com M\u00e9todo e Respaldo<\/h2>\n            <p>A metodologia AIMED forma m\u00e9dicos para usar intelig\u00eancia artificial com rigor cl\u00ednico e seguran\u00e7a regulat\u00f3ria \u2014 n\u00e3o como espectadores, mas como protagonistas. Inclui governan\u00e7a e conformidade na pr\u00e1tica, com framework de implementa\u00e7\u00e3o e casos aplicados.<\/p>\n            <a href=\"https:\/\/inovamed.pro\/?page_id=96\" class=\"cta-button\">Conhe\u00e7a o AIMED \u2192<\/a>\n        <\/div>\n        <section class=\"section\" id=\"final-pt\">\n            <h2 class=\"section-title\">Considera\u00e7\u00f5es Finais<\/h2>\n            <div class=\"intro-box\">\n                <p>A Resolu\u00e7\u00e3o 2.454 n\u00e3o freou o futuro da IA na medicina; apenas exigiu que esse futuro tenha um nome assinado embaixo. Para quem j\u00e1 usava IA com responsabilidade, ela \u00e9 al\u00edvio, n\u00e3o amea\u00e7a: transforma a zona cinzenta em terreno firme.<\/p>\n                <p>\ud83d\udca1 <strong>Connecting the Dots:<\/strong> a maior vantagem competitiva do m\u00e9dico nos pr\u00f3ximos anos n\u00e3o ser\u00e1 usar IA mais r\u00e1pido que o colega \u2014 ser\u00e1 ser a <strong>autoridade que a IA precisa para ter permiss\u00e3o de existir no hospital<\/strong>. Quem domina a classifica\u00e7\u00e3o de risco, projeta a supervis\u00e3o significativa e audita o agente \u2014 como fizemos com o ALTA \u2014 n\u00e3o apenas cumpre a norma: ocupa o lugar de quem define como a IA entra na institui\u00e7\u00e3o. Conformidade, bem feita, \u00e9 menos sobre permiss\u00e3o e mais sobre lideran\u00e7a.<\/p>\n            <\/div>\n        <\/section>\n        <section class=\"section\" id=\"ref-pt\">\n            <div class=\"reference-box\">\n                <h4>Refer\u00eancias<\/h4>\n                <ol>\n                    <li>Conselho Federal de Medicina. <em>Resolu\u00e7\u00e3o CFM n\u00ba 2.454\/2026<\/em> \u2014 normatiza o uso da intelig\u00eancia artificial na medicina. DOU 2026 fev 27; vig\u00eancia em 26\/08\/2026. Dispon\u00edvel em: https:\/\/sistemas.cfm.org.br\/normas\/arquivos\/resolucoes\/BR\/2026\/2454_2026.pdf<\/li>\n                    <li>Conselho Federal de Medicina. CFM normatiza uso da IA na medicina. <em>Portal M\u00e9dico<\/em>. 2026. Dispon\u00edvel em: https:\/\/portal.cfm.org.br\/noticias\/cfm-normatiza-uso-da-ia-na-medicina\/<\/li>\n                    <li>Medicina S\/A. O fim da IA informal: por que a nova resolu\u00e7\u00e3o exige a &#8220;IA Corporativa&#8221;. 2026. Dispon\u00edvel em: https:\/\/medicinasa.com.br\/eval-ia-corporativa\/<\/li>\n                    <li>Migalhas. Reflex\u00f5es sobre a regula\u00e7\u00e3o da IA m\u00e9dica ap\u00f3s a Resolu\u00e7\u00e3o CFM 2.454\/26. 2026.<\/li>\n                <\/ol>\n            <\/div>\n        <\/section>\n    <\/div>\n<\/div>\n<!-- ===================== CONTE\u00daDO EN ===================== -->\n<div id=\"content-en\" class=\"hidden\">\n    <section class=\"hero\" id=\"top-en\">\n        <span class=\"article-tag\">Regulation \u00b7 AI in Medicine \u00b7 Clinical Practice<\/span>\n        <h1>Use AI Without Fear: What Resolution CFM 2.454\/2026 Guarantees You<\/h1>\n        <p class=\"subtitle\">The rule many read as a threat is, in practice, the official track that protects physicians who already use artificial intelligence. A view from someone who uses \u2014 and builds \u2014 AI at the bedside.<\/p>\n        <p class=\"meta-info\">Dr. Mbula Luzingu Barros | Pediatric Intensivist \u00b7 25 years in Pediatric ICU | AI Healthcare Consultant | Founder of INOVAMED | Creator of the AIMED Methodology<\/p>\n        <p class=\"date\">\ud83d\udcc5 Published June 29, 2026<\/p>\n        <div class=\"deadline-badge\">\u23f1 CFM 2.454 enforcement in: <span class=\"countdown-days\">58<\/span> days \u2014 August 26, 2026<\/div>\n    <\/section>\n    <div class=\"container\">\n        <nav class=\"toc\" id=\"indice-en\">\n            <h2>Table of Contents<\/h2>\n            <p class=\"toc-subtitle\">From hesitation to Monday&#8217;s conduct \u2014 why the rule is on your side<\/p>\n            <ul>\n                <li><a href=\"#ctx-en\">1. The Misreading: Why So Many Got It Wrong<\/a><\/li>\n                <li><a href=\"#garante-en\">2. What CFM 2.454 Actually Guarantees<\/a><\/li>\n                <li><a href=\"#risco-en\">3. Risk Classification in Practice<\/a><\/li>\n                <li><a href=\"#informal-en\">4. From Informal AI to AI With Backing<\/a><\/li>\n                <li><a href=\"#alta-en\">5. Real Case: the ALTA Robot in the Neonatal ICU<\/a><\/li>\n                <li><a href=\"#fazer-en\">6. Compliance Checklist Before Aug 26<\/a><\/li>\n                <li><a href=\"#final-en\">7. Final Considerations<\/a><\/li>\n                <li><a href=\"#ref-en\">8. References<\/a><\/li>\n            <\/ul>\n        <\/nav>\n        <section class=\"section\" id=\"ctx-en\">\n            <h2 class=\"section-title\">The Misreading: Why So Many Got It Wrong<\/h2>\n            <div class=\"intro-box\">\n                <p>On February 27, 2026, Brazil&#8217;s Federal Council of Medicine published Resolution CFM No. 2.454\/2026 in the Official Gazette, regulating the use of artificial intelligence in medicine nationwide. The rules take effect on <strong>August 26, 2026<\/strong> \u2014 180 days after publication. The dominant reading was alarm: &#8220;CFM cracked down on AI.&#8221;<\/p>\n                <p>I propose the opposite reading, and I make it from inside the hospital. The resolution does not ban \u2014 it <strong>organizes<\/strong>. For the first time there is an official track telling you how you <em>can<\/em> use AI, with ethical, technical and legal backing. Whoever used AI in the shadows, with no trace, bore the risk alone. From now on, there is a clear rule \u2014 and a clear rule protects those who follow it.<\/p>\n            <\/div>\n        <\/section>\n        <div class=\"divider\"><\/div>\n        <section class=\"section\" id=\"garante-en\">\n            <h2 class=\"section-title\">What CFM 2.454 Actually Guarantees<\/h2>\n            <div class=\"detailed-section\">\n                <p>The rule expressly guarantees the physician&#8217;s right to use AI as support for clinical decisions, management, research and continuing medical education. Three pillars stand out:<\/p>\n                <h4>Autonomy preserved<\/h4>\n                <p>The final word on diagnosis, therapy and prognosis always remains with the physician. Moreover, physicians may refuse technologies that are not scientifically validated, lack regulatory certification, or contradict ethical, technical or legal principles.<\/p>\n                <h4>Objective selection criteria<\/h4>\n                <p>The resolution creates a risk classification \u2014 low, medium, high and unacceptable \u2014 based on impact on fundamental rights, model complexity, degree of autonomy and data sensitivity.<\/p>\n                <h4>Patient rights<\/h4>\n                <p>Clear information on health status, right to a second opinion, personal data protection, and no experimental interventions without specific consent.<\/p>\n            <\/div>\n            <div class=\"highlight-box\">\n                <h4>The point that changes your Monday<\/h4>\n                <p>AI supports; the <strong>physician decides<\/strong>. This is not a new limitation \u2014 it formalizes what good practice already required. What changed is that this practice now has backing: following the rule stopped being red tape and became armor.<\/p>\n            <\/div>\n        <\/section>\n        <div class=\"divider\"><\/div>\n        <section class=\"section\" id=\"risco-en\">\n            <h2 class=\"section-title\">Risk Classification in Practice<\/h2>\n            <div class=\"detailed-section\">\n                <p>Knowing which band each tool falls into is what separates defensible use from reckless use. The reading applied to daily clinical practice:<\/p>\n            <\/div>\n            <div class=\"table-wrapper\">\n                <table class=\"data-table\">\n                    <thead>\n                        <tr>\n                            <th>Risk band<\/th>\n                            <th>Clinical use example<\/th>\n                            <th>Practical requirement<\/th>\n                        <\/tr>\n                    <\/thead>\n                    <tbody>\n                        <tr>\n                            <td><span class=\"status-badge s-baixo\">Low<\/span><\/td>\n                            <td>Literature summary, medical education support<\/td>\n                            <td>Best practices and transparency<\/td>\n                        <\/tr>\n                        <tr>\n                            <td><span class=\"status-badge s-medio\">Medium<\/span><\/td>\n                            <td>Clinical note structuring, administrative triage<\/td>\n                            <td>Validation + documented human supervision<\/td>\n                        <\/tr>\n                        <tr>\n                            <td><span class=\"status-badge s-alto\">High<\/span><\/td>\n                            <td>Bedside diagnostic\/therapeutic decision support<\/td>\n                            <td>Certification, traceability and recorded human decision<\/td>\n                        <\/tr>\n                        <tr>\n                            <td><span class=\"status-badge s-inaceitavel\">Unacceptable<\/span><\/td>\n                            <td>Autonomous clinical decision without a responsible physician<\/td>\n                            <td>Prohibited<\/td>\n                        <\/tr>\n                    <\/tbody>\n                <\/table>\n            <\/div>\n            <div class=\"warning-box\">\n                <h4>\u26a0 Caution: classification is your responsibility<\/h4>\n                <p>Bedside decision-support tools tend to fall in the <strong>high-risk<\/strong> band. That does not ban them \u2014 it requires certification, model-version logging and proof that the final decision was human. And the formal risk assessment is the duty of the institution that uses it, not the vendor that sells it.<\/p>\n            <\/div>\n        <\/section>\n        <div class=\"divider\"><\/div>\n        <section class=\"section\" id=\"informal-en\">\n            <h2 class=\"section-title\">From Informal AI to AI With Backing<\/h2>\n            <div class=\"detailed-section\">\n                <p>The biggest practical effect of 2.454 is to end the era of &#8220;pocket AI&#8221; \u2014 the generic personal account opened on a phone during rounds, with no trace and no governance. The safe path becomes institutional, auditable and validated AI. It is not a loss of agility: it is a gain in protection.<\/p>\n            <\/div>\n            <div class=\"flow-box\">\n                <h4>The adaptation window<\/h4>\n                <p class=\"flow-intro\">Where we stand today on the norm&#8217;s timeline \u2014 and why acting now costs less.<\/p>\n                <div class=\"flow-steps\">\n                    <div class=\"flow-step\">\n                        <div class=\"step-label\">Until Feb 27, 2026<\/div>\n                        <div class=\"step-title\">Era of informal AI<\/div>\n                        <div class=\"step-desc\">Personal use, no record, full risk on the physician.<\/div>\n                    <\/div>\n                    <div class=\"flow-arrow\">\u279c<\/div>\n                    <div class=\"flow-step current\">\n                        <div class=\"step-label\">Jun 29, 2026 \u00b7 You are here<\/div>\n                        <div class=\"step-title\">Migration window open<\/div>\n                        <div class=\"step-desc\">58 days to migrate to a certified tool, with usage logs and documented human decisions.<\/div>\n                    <\/div>\n                    <div class=\"flow-arrow\">\u279c<\/div>\n                    <div class=\"flow-step\">\n                        <div class=\"step-label\">Aug 26, 2026<\/div>\n                        <div class=\"step-title\">Full enforcement<\/div>\n                        <div class=\"step-desc\">Duties become enforceable. Institutional AI as the standard \u2014 more legal certainty than before the rule.<\/div>\n                    <\/div>\n                    <div class=\"flow-arrow\">\u279c<\/div>\n                    <div class=\"flow-step\">\n                        <div class=\"step-label\">Thereafter<\/div>\n                        <div class=\"step-title\">State CRM enforcement<\/div>\n                        <div class=\"step-desc\">Regional Councils begin active oversight. Those who prepared use AI with peace of mind.<\/div>\n                    <\/div>\n                <\/div>\n            <\/div>\n        <\/section>\n        <div class=\"divider\"><\/div>\n        <section class=\"section\" id=\"alta-en\">\n            <h2 class=\"section-title\">Real Case: the ALTA Robot in the Neonatal ICU<\/h2>\n            <div class=\"detailed-section\">\n                <p>This is no distant theory for us. <strong>ALTA<\/strong> \u2014 a clinical decision-support robot INOVAMED presented at the Harvard HSIL Hackathon, Bras\u00edlia hub, in April 2026 \u2014 has entered definitive implementation in our neonatal ICU.<\/p>\n                <p>Its operating design is exactly what 2.454 prescribes: AI raises the signal and organizes information; the <strong>neonatologist<\/strong> evaluates, decides and signs every course of action. The tool does not replace clinical judgment \u2014 it amplifies early detection and frees the team&#8217;s cognitive time. We are optimistic about the gains in decision support.<\/p>\n            <\/div>\n            <div class=\"science-box\">\n                <h4>Connecting the Dots<\/h4>\n                <p>ALTA is at once a clinical tool and a regulatory proof of concept. Building the audit layer \u2014 risk classification mapped, traceability of every interaction, and the final human decision always recorded \u2014 <em>before<\/em> the rule demands it is not excess zeal.<\/p>\n                <p>It is what turns a good hackathon idea into technology that survives Council inspection. Whoever designs compliance from the prototype does not chase the rule \u2014 they arrive ahead of it.<\/p>\n            <\/div>\n        <\/section>\n        <div class=\"divider\"><\/div>\n        <section class=\"section\" id=\"fazer-en\">\n            <h2 class=\"section-title\">Compliance Checklist Before Aug 26<\/h2>\n            <div class=\"highlight-box\">\n                <h4>What to ensure before enforcement<\/h4>\n                <div class=\"checklist-section\">\n                    <div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Validation and certification.<\/strong> Ensure scientific validation and, where applicable, regulatory certification of the tool.<\/div><\/div>\n                    <div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Classify the risk of each use.<\/strong> Map low \/ medium \/ high based on Art. 12 criteria \u2014 it is the institution&#8217;s duty.<\/div><\/div>\n                    <div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Auditable log.<\/strong> A record of every physician\u2013AI interaction: prompt, response, model, version and date.<\/div><\/div>\n                    <div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Documented human decision.<\/strong> A mandatory field \u2014 never auto-filled \u2014 recording that the physician reviewed and signed.<\/div><\/div>\n                    <div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>LGPD.<\/strong> Legal basis and data protection for any patient data processed; prefer pseudonymization.<\/div><\/div>\n                    <div class=\"check-item\"><span class=\"check-icon\">\u2610<\/span><div class=\"check-text\"><strong>Patient rights.<\/strong> Clear information about AI use and respect for the right to a second opinion.<\/div><\/div>\n                <\/div>\n            <\/div>\n            <div class=\"alert-box\">\n                <h4>\u26a0 Do not leave it for later<\/h4>\n                <p>There are only a few weeks until August 26. Mapping tools and building the audit log now is cheaper than adapting under pressure \u2014 and infinitely cheaper than answering an inquiry with no trail.<\/p>\n            <\/div>\n        <\/section>\n        <div class=\"cta-section\">\n            <h2>Use AI With Method and Backing<\/h2>\n            <p>The AIMED methodology develops physicians who use artificial intelligence with clinical rigor and regulatory safety \u2014 not as spectators, but as protagonists. It includes governance and compliance in practice, with an implementation framework and applied cases.<\/p>\n            <a href=\"https:\/\/inovamed.pro\/?page_id=96\" class=\"cta-button\">Discover AIMED \u2192<\/a>\n        <\/div>\n        <section class=\"section\" id=\"final-en\">\n            <h2 class=\"section-title\">Final Considerations<\/h2>\n            <div class=\"intro-box\">\n                <p>Resolution 2.454 did not stop the future of AI in medicine; it merely required that this future carry a signed name beneath it. For those who already used AI responsibly, it is relief, not threat: it turns the gray zone into firm ground.<\/p>\n                <p>\ud83d\udca1 <strong>Connecting the Dots:<\/strong> the physician&#8217;s greatest competitive edge in the coming years will not be using AI faster than a colleague \u2014 it will be being the <strong>authority the AI needs in order to be allowed to exist in the hospital<\/strong>. Whoever masters risk classification, designs significant supervision, and audits the agent \u2014 as we did with ALTA \u2014 does not merely comply: they take the seat of those who define how AI enters the institution. Compliance, done well, is less about permission and more about leadership.<\/p>\n            <\/div>\n        <\/section>\n        <section class=\"section\" id=\"ref-en\">\n            <div class=\"reference-box\">\n                <h4>References<\/h4>\n                <ol>\n                    <li>Federal Council of Medicine (CFM). <em>Resolution CFM No. 2,454\/2026<\/em> \u2014 regulating the use of artificial intelligence in medicine. Official Gazette 2026 Feb 27; effective Aug 26, 2026. Available at: https:\/\/sistemas.cfm.org.br\/normas\/arquivos\/resolucoes\/BR\/2026\/2454_2026.pdf<\/li>\n                    <li>Federal Council of Medicine. CFM regulates AI use in medicine. <em>Portal M\u00e9dico<\/em>. 2026. Available at: https:\/\/portal.cfm.org.br\/noticias\/cfm-normatiza-uso-da-ia-na-medicina\/<\/li>\n                    <li>Medicina S\/A. The end of informal AI: why the new resolution requires &#8220;Corporate AI&#8221;. 2026. Available at: https:\/\/medicinasa.com.br\/eval-ia-corporativa\/<\/li>\n                <\/ol>\n            <\/div>\n        <\/section>\n    <\/div>\n<\/div>\n<!-- FOOTER -->\n<div class=\"footer\">\n    <p><strong>Dr. Mbula Luzingu Barros<\/strong><\/p>\n    <p id=\"footer-specialty-pt\">M\u00e9dico Pediatra Intensivista \u00b7 25 anos de UTI | Consultor em IA na Sa\u00fade | Fundador da INOVAMED | Criador da Metodologia AIMED<\/p>\n    <p id=\"footer-specialty-en\" class=\"hidden\">Pediatric Intensivist \u00b7 25 years in ICU | AI Healthcare Consultant | Founder of INOVAMED | Creator of the AIMED Methodology<\/p>\n    <p style=\"margin-top: 20px; opacity: 0.65; font-size: 0.9rem;\">\u00a9 2026 inovamed.pro \u2014 Este artigo pode ser compartilhado com atribui\u00e7\u00e3o ao autor \u00b7 This article may be shared with attribution to the author<\/p>\n<\/div>\n<script>\nfunction switchLanguage(lang) {\n    var ptC = document.getElementById('content-pt');\n    var enC = document.getElementById('content-en');\n    var btnPt = document.getElementById('btn-pt');\n    var btnEn = document.getElementById('btn-en');\n    var navBtnTop = document.getElementById('nav-btn-top');\n    var navBtnToc = document.getElementById('nav-btn-toc');\n    var footerPt = document.getElementById('footer-specialty-pt');\n    var footerEn = document.getElementById('footer-specialty-en');\n    if (lang === 'pt') {\n        ptC.classList.remove('hidden'); enC.classList.add('hidden');\n        btnPt.classList.add('active'); btnEn.classList.remove('active');\n        document.documentElement.lang = 'pt-BR';\n        navBtnTop.href = '#top-pt'; navBtnToc.href = '#indice-pt';\n        footerPt.classList.remove('hidden'); footerEn.classList.add('hidden');\n    } else {\n        ptC.classList.add('hidden'); enC.classList.remove('hidden');\n        btnPt.classList.remove('active'); btnEn.classList.add('active');\n        document.documentElement.lang = 'en';\n        navBtnTop.href = '#top-en'; navBtnToc.href = '#indice-en';\n        footerPt.classList.add('hidden'); footerEn.classList.remove('hidden');\n    }\n}\nfunction updateCountdown() {\n    var target = new Date('2026-08-26T00:00:00');\n    var now = new Date();\n    var diff = target - now;\n    if (diff > 0) {\n        var days = Math.ceil(diff \/ (1000 * 60 * 60 * 24));\n        document.querySelectorAll('.countdown-days').forEach(function(el) { el.textContent = days; });\n    }\n}\ndocument.addEventListener('DOMContentLoaded', function() {\n    switchLanguage('pt');\n    updateCountdown();\n});\nupdateCountdown();\n<\/script>\n<\/div>","protected":false},"excerpt":{"rendered":"<p>\u2191 \ud83e\udded \ud83c\udde7\ud83c\uddf7 PT \ud83c\uddfa\ud83c\uddf8 EN Regula\u00e7\u00e3o \u00b7 IA na Medicina \u00b7 Pr\u00e1tica Cl\u00ednica Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea A norma que muitos leram como amea\u00e7a \u00e9, na pr\u00e1tica, o trilho oficial que protege o m\u00e9dico que j\u00e1 usa intelig\u00eancia artificial. Um<span class=\"more-link\"><a href=\"https:\/\/inovamed.pro\/?p=2777\">LEIA O ARTIGO COMPLETO<\/a><\/span><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["entry","author-mbulabarros","post-2777","post","type-post","status-publish","format-standard","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v23.9 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea - INOVAMED<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/inovamed.pro\/?p=2777\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea - INOVAMED\" \/>\n<meta property=\"og:description\" content=\"\u2191 \ud83e\udded \ud83c\udde7\ud83c\uddf7 PT \ud83c\uddfa\ud83c\uddf8 EN Regula\u00e7\u00e3o \u00b7 IA na Medicina \u00b7 Pr\u00e1tica Cl\u00ednica Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea A norma que muitos leram como amea\u00e7a \u00e9, na pr\u00e1tica, o trilho oficial que protege o m\u00e9dico que j\u00e1 usa intelig\u00eancia artificial. UmLEIA O ARTIGO COMPLETO\" \/>\n<meta property=\"og:url\" content=\"https:\/\/inovamed.pro\/?p=2777\" \/>\n<meta property=\"og:site_name\" content=\"INOVAMED\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-29T21:42:42+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-29T21:45:17+00:00\" \/>\n<meta name=\"author\" content=\"mbulabarros\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"mbulabarros\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. tempo de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"15 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/inovamed.pro\/?p=2777#article\",\"isPartOf\":{\"@id\":\"https:\/\/inovamed.pro\/?p=2777\"},\"author\":{\"name\":\"mbulabarros\",\"@id\":\"https:\/\/inovamed.pro\/#\/schema\/person\/f023d988086a844cf27e25d0dd97e239\"},\"headline\":\"Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea\",\"datePublished\":\"2026-06-29T21:42:42+00:00\",\"dateModified\":\"2026-06-29T21:45:17+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/inovamed.pro\/?p=2777\"},\"wordCount\":2803,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/inovamed.pro\/#organization\"},\"articleSection\":[\"Uncategorized\"],\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/inovamed.pro\/?p=2777#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/inovamed.pro\/?p=2777\",\"url\":\"https:\/\/inovamed.pro\/?p=2777\",\"name\":\"Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea - INOVAMED\",\"isPartOf\":{\"@id\":\"https:\/\/inovamed.pro\/#website\"},\"datePublished\":\"2026-06-29T21:42:42+00:00\",\"dateModified\":\"2026-06-29T21:45:17+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/inovamed.pro\/?p=2777#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/inovamed.pro\/?p=2777\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/inovamed.pro\/?p=2777#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/inovamed.pro\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/inovamed.pro\/#website\",\"url\":\"https:\/\/inovamed.pro\/\",\"name\":\"INOVAMED\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/inovamed.pro\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/inovamed.pro\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/inovamed.pro\/#organization\",\"name\":\"INOVAMED\",\"url\":\"https:\/\/inovamed.pro\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/inovamed.pro\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/inovamed.pro\/wp-content\/uploads\/2024\/12\/cropped-DALL\u00b7E-2024-12-10-13.53.06-A-hyperrealistic-3D-rendering-of-a-half-human-brain-merged-with-circuit-board-patterns-viewed-from-a-slight-side-angle.-The-brains-left-hemisphere-s.webp\",\"contentUrl\":\"https:\/\/inovamed.pro\/wp-content\/uploads\/2024\/12\/cropped-DALL\u00b7E-2024-12-10-13.53.06-A-hyperrealistic-3D-rendering-of-a-half-human-brain-merged-with-circuit-board-patterns-viewed-from-a-slight-side-angle.-The-brains-left-hemisphere-s.webp\",\"width\":1706,\"height\":1023,\"caption\":\"INOVAMED\"},\"image\":{\"@id\":\"https:\/\/inovamed.pro\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/inovamed.pro\/#\/schema\/person\/f023d988086a844cf27e25d0dd97e239\",\"name\":\"mbulabarros\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\/\/inovamed.pro\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/b45ea8fc03f19632f2c0e1180c867958fb387b48b3fe9af6e41ad80bbcf0d3c9?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/b45ea8fc03f19632f2c0e1180c867958fb387b48b3fe9af6e41ad80bbcf0d3c9?s=96&d=mm&r=g\",\"caption\":\"mbulabarros\"},\"sameAs\":[\"https:\/\/inovamed.pro\"],\"url\":\"https:\/\/inovamed.pro\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea - INOVAMED","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/inovamed.pro\/?p=2777","og_locale":"pt_BR","og_type":"article","og_title":"Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea - INOVAMED","og_description":"\u2191 \ud83e\udded \ud83c\udde7\ud83c\uddf7 PT \ud83c\uddfa\ud83c\uddf8 EN Regula\u00e7\u00e3o \u00b7 IA na Medicina \u00b7 Pr\u00e1tica Cl\u00ednica Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea A norma que muitos leram como amea\u00e7a \u00e9, na pr\u00e1tica, o trilho oficial que protege o m\u00e9dico que j\u00e1 usa intelig\u00eancia artificial. UmLEIA O ARTIGO COMPLETO","og_url":"https:\/\/inovamed.pro\/?p=2777","og_site_name":"INOVAMED","article_published_time":"2026-06-29T21:42:42+00:00","article_modified_time":"2026-06-29T21:45:17+00:00","author":"mbulabarros","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"mbulabarros","Est. tempo de leitura":"15 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/inovamed.pro\/?p=2777#article","isPartOf":{"@id":"https:\/\/inovamed.pro\/?p=2777"},"author":{"name":"mbulabarros","@id":"https:\/\/inovamed.pro\/#\/schema\/person\/f023d988086a844cf27e25d0dd97e239"},"headline":"Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea","datePublished":"2026-06-29T21:42:42+00:00","dateModified":"2026-06-29T21:45:17+00:00","mainEntityOfPage":{"@id":"https:\/\/inovamed.pro\/?p=2777"},"wordCount":2803,"commentCount":0,"publisher":{"@id":"https:\/\/inovamed.pro\/#organization"},"articleSection":["Uncategorized"],"inLanguage":"pt-BR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/inovamed.pro\/?p=2777#respond"]}]},{"@type":"WebPage","@id":"https:\/\/inovamed.pro\/?p=2777","url":"https:\/\/inovamed.pro\/?p=2777","name":"Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea - INOVAMED","isPartOf":{"@id":"https:\/\/inovamed.pro\/#website"},"datePublished":"2026-06-29T21:42:42+00:00","dateModified":"2026-06-29T21:45:17+00:00","breadcrumb":{"@id":"https:\/\/inovamed.pro\/?p=2777#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/inovamed.pro\/?p=2777"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/inovamed.pro\/?p=2777#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/inovamed.pro\/"},{"@type":"ListItem","position":2,"name":"Use IA Sem Medo: O Que a Resolu\u00e7\u00e3o CFM 2.454\/2026 Garante a Voc\u00ea"}]},{"@type":"WebSite","@id":"https:\/\/inovamed.pro\/#website","url":"https:\/\/inovamed.pro\/","name":"INOVAMED","description":"","publisher":{"@id":"https:\/\/inovamed.pro\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/inovamed.pro\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/inovamed.pro\/#organization","name":"INOVAMED","url":"https:\/\/inovamed.pro\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/inovamed.pro\/#\/schema\/logo\/image\/","url":"https:\/\/inovamed.pro\/wp-content\/uploads\/2024\/12\/cropped-DALL\u00b7E-2024-12-10-13.53.06-A-hyperrealistic-3D-rendering-of-a-half-human-brain-merged-with-circuit-board-patterns-viewed-from-a-slight-side-angle.-The-brains-left-hemisphere-s.webp","contentUrl":"https:\/\/inovamed.pro\/wp-content\/uploads\/2024\/12\/cropped-DALL\u00b7E-2024-12-10-13.53.06-A-hyperrealistic-3D-rendering-of-a-half-human-brain-merged-with-circuit-board-patterns-viewed-from-a-slight-side-angle.-The-brains-left-hemisphere-s.webp","width":1706,"height":1023,"caption":"INOVAMED"},"image":{"@id":"https:\/\/inovamed.pro\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/inovamed.pro\/#\/schema\/person\/f023d988086a844cf27e25d0dd97e239","name":"mbulabarros","image":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/inovamed.pro\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/b45ea8fc03f19632f2c0e1180c867958fb387b48b3fe9af6e41ad80bbcf0d3c9?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/b45ea8fc03f19632f2c0e1180c867958fb387b48b3fe9af6e41ad80bbcf0d3c9?s=96&d=mm&r=g","caption":"mbulabarros"},"sameAs":["https:\/\/inovamed.pro"],"url":"https:\/\/inovamed.pro\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/inovamed.pro\/index.php?rest_route=\/wp\/v2\/posts\/2777","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/inovamed.pro\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/inovamed.pro\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/inovamed.pro\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/inovamed.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=2777"}],"version-history":[{"count":2,"href":"https:\/\/inovamed.pro\/index.php?rest_route=\/wp\/v2\/posts\/2777\/revisions"}],"predecessor-version":[{"id":2779,"href":"https:\/\/inovamed.pro\/index.php?rest_route=\/wp\/v2\/posts\/2777\/revisions\/2779"}],"wp:attachment":[{"href":"https:\/\/inovamed.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=2777"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/inovamed.pro\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=2777"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/inovamed.pro\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=2777"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}